![](/images/graphics-bg.png)
Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage
المؤلفون المشاركون
Zhao, Peiquan
Xu, Yu
Kang, Xiaoli
Zhang, Qi
Huang, Qiujing
Lv, Jiao
المصدر
العدد
المجلد 2016، العدد 2016 (31 ديسمبر/كانون الأول 2016)، ص ص. 1-6، 6ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2016-12-14
دولة النشر
مصر
عدد الصفحات
6
التخصصات الرئيسية
الملخص EN
To investigate the efficacy of intravitreal ranibizumab (IVR) combined with laser photocoagulation for aggressive posterior retinopathy of prematurity (AP-ROP) patients with vitreous hemorrhage, we conducted a retrospective observational case series study.
A total of 37 eyes of 20 patients’ medical records were reviewed.
Patients first received IVR (0.25 mg/0.025 mL) and later photocoagulation.
The mean postconceptual age of injection was 34.6 ± 1.4 weeks, and the mean follow-up period was 39.3 ± 8.3 weeks.
During the follow-up, 96.6% eyes had various degree of rapid absorption of vitreous hemorrhage after IVR.
The mean time of received first photocoagulation after IVR was 4.8 ± 2.9 weeks.
Ten (27.0%) eyes received second laser therapy and the mean time of second laser therapy after IVR was 3.2 ± 0.8 weeks.
All eyes exhibited adequate regression of ROP and were stable with attached retina.
Fibrosis membrane was observed in seven eyes (18.9%) and three of them demonstrated mild ectopic macula.
No significant side effects related to IVR were observed.
So IVR could be conducted as primary treatment of AP-ROP associated with vitreous hemorrhage, which can improve the fundus visibility, followed by conventional photocoagulation.
Further randomized controlled trials are necessary to compare the clinical efficacy and safety with conventional interventions.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Xu, Yu& Kang, Xiaoli& Zhang, Qi& Huang, Qiujing& Lv, Jiao& Zhao, Peiquan. 2016. Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage. Journal of Ophthalmology،Vol. 2016, no. 2016, pp.1-6.
https://search.emarefa.net/detail/BIM-1109979
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Xu, Yu…[et al.]. Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage. Journal of Ophthalmology No. 2016 (2016), pp.1-6.
https://search.emarefa.net/detail/BIM-1109979
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Xu, Yu& Kang, Xiaoli& Zhang, Qi& Huang, Qiujing& Lv, Jiao& Zhao, Peiquan. Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage. Journal of Ophthalmology. 2016. Vol. 2016, no. 2016, pp.1-6.
https://search.emarefa.net/detail/BIM-1109979
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1109979
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)